Details
| Opportunity Name | Awards for Excellence in Cancer Research |
| Agency | Canadian Cancer Society |
| Value | $20,000 |
| Indirect Costs | Ineligible |
| Duration | N/A |
Deadlines
| Application due to FSc RO at sciapps@yorku.ca for full review | 11-27-2024 |
| Application and fully signed ORS checklist due to FSc RO at sciapps@yorku.ca for mandatory review | 12-04-2024 |
| Final application and fully signed ORS checklist due at ORS for mandatory review | 12-09-2024, by 9:00AM |
| Application due at agency | 12-11-2024, by 5:00PM |
Objective
Lifetime Contribution Prize
This award is given to an esteemed investigator whose contributions to cancer research in Canada extend beyond traditional research accomplishments and outputs.
Inclusive Excellence Prize
This award is given to an individual who has demonstrated leadership and impact in the advancement of equity, diversity, inclusion and accessibility as it relates to the cancer research ecosystem in Canada.
O. Harold Warwick Prize
The recipient of this award will be an investigator permanently residing in Canada whose contributions have led to significant advances in cancer control and who is, normally engaged in the conduct of cancer research.
Robert L. Noble Prize
This award is given for outstanding achievements in basic biomedical cancer research.
Bernard and Francine Dorval Prize
This award is given to an early career investigator whose outstanding contributions to basic biomedical research have the potential to lead or have already led to improved understanding of cancer treatments/or cures.
William E. Rawls Prize
This award is given to an early career investigator whose outstanding contributions have the potential to lead to or have already led to important advances in cancer control.
Eligibility
Lifetime Contribution Prize
The recipient of this award will be an individual permanently residing in Canada who has enhanced the Canadian cancer research landscape through their vision and leadership in the development of networks, collaborations, resources, and/or infrastructure that have/has significantly benefitted people in Canada affected by cancer. In addition, the recipient of this award has demonstrated a deep commitment to training the next generation of researchers.
Inclusive Excellence Prize
The recipient of this award will be an individual permanently residing in Canada whose efforts reflect a genuine commitment to fostering inclusive excellence and whose work has led to significant, measurable impacts that may include greater diversity in Canada’s cancer landscape, and/or enhanced equity in the delivery of cancer care of underserved populations.
O. Harold Warwick Prize
For the purposes of this award, cancer control is meant to include clinical (including clinical trials), health services, epidemiological, behavioural, psychosocial, population-based research or similarly applied research aimed at reducing the burden of cancer and does not include research in the basic biomedical sciences.
Robert L. Noble Prize
The recipient of this award will be an investigator permanently residing in Canada whose contributions have led to significant accomplishments in a body of work in basic biomedical cancer research and who is, normally, still engaged in the conduct of cancer research.
Bernard and Francine Dorval Prize
The recipient of this award will be an early career investigator permanently residing in Canada who began their independent research career within the previous 10 years. All those who began their independent research career after December 31, 2014, will be eligible for nomination.
William E. Rawls Prize
The recipient of this award will be a Canadian investigator permanently residing in Canada who began their independent research career within the previous 10 years. All those who began their independent research career after December 31, 2014, will be eligible for nomination.
For the purposes of this award, cancer control is meant to include clinical (including clinical trials), health services, epidemiological, behavioural, psychosocial, population-based research or similarly applied research aimed at reducing the burden of cancer and does not include research in the basic biomedical sciences.
How to Apply
York University researchers are reminded that all applications for external research funding, including Letters of Intent, must be reviewed and approved by the Office of Research Services before they are submitted to the granting agency. For internal approval, the application must be accompanied by a completed ORS Checklist, which requires the Dean’s signature. Please send the complete application, with the finalized budget and a completed ORS checklist to sciapps@yorku.ca, five days prior to agency deadline.
ORS is accepting electronic applications – the process is outlined here.